Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-7.02%
operating margin TTM
-12.44%
revenue TTM
237.34 Million
revenue per share TTM
8.13$
valuation ratios | |
|---|---|
| pe ratio | -33.50 |
| peg ratio | 0.34 |
| price to book ratio | 1.72 |
| price to sales ratio | 2.34 |
| enterprise value multiple | 67.40 |
| price fair value | 1.72 |
profitability ratios | |
|---|---|
| gross profit margin | 68.66% |
| operating profit margin | -12.44% |
| pretax profit margin | -8.57% |
| net profit margin | -7.02% |
| return on assets | -4.18% |
| return on equity | -5.27% |
| return on capital employed | -8.4% |
liquidity ratios | |
|---|---|
| current ratio | 5.26 |
| quick ratio | 5.11 |
| cash ratio | 1.70 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 34.69 |
| operating cycle | 80.69 |
| days of payables outstanding | 63.30 |
| cash conversion cycle | 17.39 |
| receivables turnover | 7.93 |
| payables turnover | 5.77 |
| inventory turnover | 10.52 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.07 |
| total debt to capitalization | 0.07 |
| interest coverage | -497.79 |
| cash flow to debt ratio | 1.74 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.97 |
| cash per share | 10.21 |
| operating cash flow per share | 2.19 |
| free cash flow operating cash flow ratio | 0.44 |
| cash flow coverage ratios | 1.74 |
| short term coverage ratios | 36.94 |
| capital expenditure coverage ratio | 1.79 |
Frequently Asked Questions
When was the last time Castle Biosciences, Inc. (NASDAQ:CSTL) reported earnings?
Castle Biosciences, Inc. (CSTL) published its most recent earnings results on 03-11-2025.
What is Castle Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Castle Biosciences, Inc. (NASDAQ:CSTL)'s trailing twelve months ROE is -5.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Castle Biosciences, Inc. (CSTL) currently has a ROA of -4.18%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CSTL's net profit margin stand at?
CSTL reported a profit margin of -7.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CSTL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.26 in the most recent quarter. The quick ratio stood at 5.11, with a Debt/Eq ratio of 0.08.